ECYT Share Price

Open 2.73 Change Price %
High 2.79 1 Day 0.02 0.73
Low 2.64 1 Week 0.14 5.32
Close 2.77 1 Month -0.19 -6.42
Volume 173528 1 Year -1.28 -31.60
52 Week High 4.33
52 Week Low 0.00
ECYT Important Levels
Resistance 2 2.91
Resistance 1 2.85
Pivot 2.73
Support 1 2.69
Support 2 2.63
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
ETRM 0.07 40.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.66 1.08%
MU 20.66 1.08%
More..
NASDAQ USA Top Gainers Stocks
SSH 0.58 176.19%
SSH 0.58 176.19%
SSH 0.58 176.19%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
MBLX 0.51 64.52%
COOL 5.17 63.61%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SHIP 1.20 -45.45%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Endocyte, Inc. (NASDAQ: ECYT)

ECYT Technical Analysis 5
As on 8th Dec 2016 ECYT Share Price closed @ 2.77 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.25 & Strong Sell for SHORT-TERM with Stoploss of 2.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
ECYT Target for December
1st Target up-side 2.99
2nd Target up-side 3.22
3rd Target up-side 3.45
1st Target down-side 2.33
2nd Target down-side 2.1
3rd Target down-side 1.87
ECYT Other Details
Segment EQ
Market Capital 285173408.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.endocyte.com
ECYT Address
ECYT
3000 Kent Avenue
Suite A1-100
West Lafayette, IN 47906
United States
Phone: 765-463-7175
Fax: 765-463-9271
Interactive Technical Analysis Chart Endocyte, Inc. ( ECYT NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Endocyte, Inc.
ECYT Business Profile
Endocyte, Inc. (Endocyte) is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its technology to create small molecule drug conjugates (SMDCs), and companion imaging diagnostics. Its SMDCs target receptors that are over-expressed on diseased cells, primarily to healthy cells. The Company�s SMDCs consists of three modules: a targeting ligand, a linker and a drug payload. The foundation of its technology is its small molecule targeting ligands, which bind to over-expressed receptors on target cells, while avoiding healthy cells. It is developing a number of different targeting ligands for a range of cancers and inflammatory diseases. Its linker system attaches the targeting ligand to the drug payload. The drug payload is the biologically active component of its SMDCs. Endocyte�s core SMDC, EC145, targets the folate receptor.